![Pharmaceuticals | Free Full-Text | Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Pharmaceuticals | Free Full-Text | Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment,](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-12-00009/article_deploy/html/images/pharmaceuticals-12-00009-g005.png)
Pharmaceuticals | Free Full-Text | Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment,
![A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine - ScienceDirect A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120799544-gr1.jpg)
A novel treatment of childhood lymphoblastic non-Hodgkin's lymphoma: early and intermittent use of teniposide plus cytarabine - ScienceDirect
![PDF) Methotrexate in juvenile idiopathic arthritis: Advice and recommendations from the MARAJIA expert consensus meeting PDF) Methotrexate in juvenile idiopathic arthritis: Advice and recommendations from the MARAJIA expert consensus meeting](https://i1.rgstatic.net/publication/326338610_Methotrexate_in_juvenile_idiopathic_arthritis_Advice_and_recommendations_from_the_MARAJIA_expert_consensus_meeting/links/5b46ae84aca272c60937853f/largepreview.png)
PDF) Methotrexate in juvenile idiopathic arthritis: Advice and recommendations from the MARAJIA expert consensus meeting
![Sphingosine Kinase Inhibition Enhances Dimerization of Calreticulin at the Cell Surface in Mitoxantrone-Induced Immunogenic Cell Death | Journal of Pharmacology and Experimental Therapeutics Sphingosine Kinase Inhibition Enhances Dimerization of Calreticulin at the Cell Surface in Mitoxantrone-Induced Immunogenic Cell Death | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/378/3/300/F2.large.jpg)
Sphingosine Kinase Inhibition Enhances Dimerization of Calreticulin at the Cell Surface in Mitoxantrone-Induced Immunogenic Cell Death | Journal of Pharmacology and Experimental Therapeutics
![Frontiers | Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis | Immunology Frontiers | Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis | Immunology](https://www.frontiersin.org/files/Articles/409124/fimmu-09-02269-HTML-r1/image_m/fimmu-09-02269-g001.jpg)
Frontiers | Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis | Immunology
Adaptation and Clinical Evaluation of a Homogenous Enzyme Multiplied Immunoassay Technique (EMIT) for Drug Monitoring of a Metho
![Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis | Arthritis Research & Therapy | Full Text Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis | Arthritis Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-021-02492-0/MediaObjects/13075_2021_2492_Fig1_HTML.png)
Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis | Arthritis Research & Therapy | Full Text
![2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis - Onel - 2022 - Arthritis & ... 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis - Onel - 2022 - Arthritis & ...](https://onlinelibrary.wiley.com/cms/asset/a4c3d92c-fccc-4135-853e-d07d4de454de/art42037-fig-0001-m.jpg)